<prompt> . All of the following statements about the use of spironolactone in CHF are true exceptIt should be administered in low doses to prevent hyperkalemialIt affords prognostic benefit in severe hea failure over and above that afforded by ACE inhibitorsIt helps to overcome the refractoriness to thiazidesIt affords rapid symptomatic relief in CHF patients  <response>: Ref KDT 6e p507 Loop diuretics are used to provide rapid symptomatic relief whereas aldosterone antagonists decrease the moality by reversing myocardial remodeling 